-
'Breast cancer enters age of precision: a happy concern for Korean clinicians'
21 Jul 2025 06:08 GMT
… -) breast cancer is the most common subtype among breast cancer patients. … HR+/HER2-) breast cancer patients with PIK3CA mutations. … dramatically expanded their treatment options. Patients who were … the triple-negative breast cancer barrier
Trodelvy’s …
-
Strictly's Amy Dowden says she thinks about her breast cancer coming back 'most days'
18 Jul 2025 19:43 GMT
… diagnosis of stage three breast cancer back in 2023. Following … emotional rollercoaster experienced after active breast cancer treatment.
Amy took to … t fully celebrate.
"Breast cancer recurrence is on my mind … ;t know what my options are going to look …
-
Quercetin: A Natural Ally in Combating Breast Cancer
18 Jul 2025 12:57 GMT
… an efficacious therapeutic option in the management of breast cancer.
Drug Micelles
… precise and effective therapeutic options for breast cancer patients.
Funding
This research … -suppression of tumor microenvironment for breast tumor-bearing mice. Sci Rep. …
-
Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy
18 Jul 2025 12:57 GMT
… -negative early breast cancer. Curr Treat Options Oncol. 2024 … chemotherapy in breast cancer patients. Clin Breast Cancer. 2020;20 … in early-stage breast cancer. Breast Cancer Res Treat. 2023 … breast cancer for assessment in small biopsies. Breast Cancer …
-
US FDA grants breakthrough therapy designation to Daiichi Sankyo & AstraZeneca’s Enhertu plus pertuzumab to treat unresectable or metastatic HER2 positive breast cancer
18 Jul 2025 08:35 GMT
… metastatic HER2 positive breast cancer.
Enhertu is … breast cancer, later-line HER2 positive metastatic breast cancer, later-line HER2 low metastatic breast cancer … positive metastatic breast cancer is an aggressive … alternative treatment options based on …
-
Breast cancer drug ALERT: Seasoned medical writer Dr. Vernon Coleman CONDEMNS ZOLADEX saying itâs dangerous, ineffective and misused
18 Jul 2025 07:48 GMT
… protocols, has called out the breast cancer drug Zoladex (goserelin) as … to critically evaluate their treatment options and reject unnecessary, harmful medications … exacerbate disease and disorder, including breast cancer.
Sources for this article include …
-
If approved, Kisqali will intensify competition in early-stage breast cancer drug prescription
18 Jul 2025 04:42 GMT
… adjuvant therapy after early breast cancer surgery.
Health insurance … breast cancer in Korea, which will further increase treatment options. … study in metastatic breast cancer demonstrated clinical utility … expansion in early breast cancer based on appropriate …
-
Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer
18 Jul 2025 03:07 GMT
… or metastatic HER2-positive breast cancer, according to a … metastatic HER2-positive positive breast cancer,” Dr. Sara M. … option for patients with metastatic HER2-positive breast cancer,… with HER2 Positive Metastatic Breast Cancer." News Release. …
-
What to Make of a New Study on HT and Breast Cancer
17 Jul 2025 23:45 GMT
… already linked progestins to breast cancer (although some have a … no longer first-line treatment options for most U.S. … a lower potential risk of breast cancer.
However, some perimenopausal … be associated with early-onset breast cancer. The results “would not …
-
DESTINY-Breast09 Data Spark Debate on Sequencing and Frontline Maintenance Strategies in HER2+ Breast Cancer
17 Jul 2025 22:29 GMT
… patients with metastatic HER2-positive breast cancer. It specifically enrolled patients … still need novel ADC options for patients with HER2-positive … , fourth-, and fifth-line options.
An area of unmet need … [therapies] . Our SOC options don’t tend to work …
About
© 1995-2025